SCHEMBL5489246

SCHEMBL5489246

CS(=O)(=O)c1ccccc1CCC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.47
PTGER1 P34995 1/20 0.45
PTGER4 P35408 1/20 0.45
PTGER3 P43115 1/20 0.45
PTGER2 P43116 1/20 0.45
FFAR1 O14842 4/20 0.44
NPSR1 Q6W5P4 2/20 0.44
TDP1 Q9NUW8 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
BCAT2 O15382 1/20 0.42
APEX1 P27695 1/20 0.42
ALDH1A1 P00352 1/20 0.41
MMP2 P08253 2/20 0.41
MMP8 P22894 2/20 0.41
MMP12 P39900 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15303316 0.84 KEAP1 (0.48) KEAP1PTGER1PTGER4PTGER3PTGER2
SCHEMBL23665900 0.83 PARP1 (0.42) KEAP1PTGER1PTGER4PTGER3PTGER2
SCHEMBL31027927 0.83 APEX1 (0.41) KEAP1PTGER1PTGER4PTGER3PTGER2
Hydrochloric Acid SCHEMBL28765686 0.82 APEX1 (0.41) KEAP1PTGER1PTGER4PTGER3PTGER2
SCHEMBL7351477 0.82 CA2 (0.50) KEAP1PTGER1PTGER4PTGER3PTGER2
SCHEMBL6069328 0.81 MMP2 (0.58) TDP1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL17848762 0.79 MEN1 (0.42) TDP1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL59198 0.78 KEAP1 (0.65) KEAP1PTGER1PTGER4PTGER3PTGER2
SCHEMBL10181521 0.77 DRD2 (0.42) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL3845969 0.76 MEN1 (0.40) MEN1KMT2ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7220780-B2 Naaladase inhibitors for treating retinal disorders and glaucoma GUILFORD PHARMACEUTICALS INC. (US) 2007-05-22 US disclosed